Zithromax-SR 2g, Special Investigation (Regulatory Post Marketing Commitment Plan)

NCT00998309 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 502

Last updated 2012-05-01

Study results available
· View outcomes & findings →

Summary

To collect the efficacy and safety information of Zithromax-SR related to their appropriate use in daily practice.

Conditions

Interventions

DRUG

Azithromycin SR

Zithromax SR 2g, taking once for treatment.

Sponsors & Collaborators

Principal Investigators

  • Pfizer CT.gov Call Center · Pfizer

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-10-31
Primary Completion
2011-01-31
Completion
2011-01-31

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00998309 on ClinicalTrials.gov